4
Changes in Ownership
Odyssey Health, Inc. Filed Acc 0001683168-22-008022
Options or other derivatives
- Chief Commercial Officer acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Emerson Erik C. Chief Commercial Officer | 2022-11-01 | Grant or award · Stock Option - Right to buy | +125,000 | $0.25 | $31,250 | 125,000 | D: show line 1 in the form | |||
| Emerson Erik C. Chief Commercial Officer | 2022-11-01 | Grant or award · Stock Option - Right to buy | +475,000 | $0.25 | $118,750 | 0 | D: show line 2 in the form |
Loading xslF345X03/ownership.xml…